OTCMKTS:ITHUF iAnthus Capital (ITHUF) Stock Price, News & Analysis $0.0045 +0.00 (+12.50%) As of 06/13/2025 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock About iAnthus Capital Stock (OTCMKTS:ITHUF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iAnthus Capital alerts:Sign Up Key Stats Today's Range$0.0040▼$0.004550-Day Range$0.0035▼$0.008152-Week Range$0.00▼$0.02Volume4,607 shsAverage Volume462,740 shsMarket CapitalizationN/AP/E Ratio0.03Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewiAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in Toronto, Canada.Read More… iAnthus Capital Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreITHUF MarketRank™: iAnthus Capital scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for iAnthus Capital. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iAnthus Capital is 0.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.30.Price to Earnings Ratio vs. SectorThe P/E ratio of iAnthus Capital is 0.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.78. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares ShortedShort Interest Ratio / Days to CoveriAnthus Capital has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iAnthus Capital has recently decreased by 50.47%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiAnthus Capital does not currently pay a dividend.Dividend GrowthiAnthus Capital does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoveriAnthus Capital has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iAnthus Capital has recently decreased by 50.47%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News SentimentN/A News SentimentiAnthus Capital has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for iAnthus Capital this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iAnthus Capital insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.34% of the stock of iAnthus Capital is held by institutions.Read more about iAnthus Capital's insider trading history. Receive ITHUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address ITHUF Stock News HeadlinesIanthus Capital Holdings IncMay 17, 2025 | investing.comiAnthus Capital Holdings, Inc.: iAnthus Reports First Quarter 2025 Financial ResultsMay 13, 2025 | finanznachrichten.deTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. June 14, 2025 | Paradigm Press (Ad)iAnthus Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comiAnthus Reports Fiscal Fourth Quarter and Full Year 2024 Financial ResultsMarch 24, 2025 | globenewswire.comiAnthus Expands Presence in Florida with New GrowHealthy Dispensary in JacksonvilleFebruary 26, 2025 | financialpost.comiAnthus Expands Presence in Florida with New GrowHealthy Dispensary in JacksonvilleFebruary 26, 2025 | financialpost.comiAnthus Expands Presence in Florida with New GrowHealthy Dispensary in JacksonvilleFebruary 26, 2025 | globenewswire.comSee More Headlines ITHUF Stock Analysis - Frequently Asked Questions How have ITHUF shares performed this year? iAnthus Capital's stock was trading at $0.0048 at the beginning of the year. Since then, ITHUF stock has decreased by 6.3% and is now trading at $0.0045. View the best growth stocks for 2025 here. How do I buy shares of iAnthus Capital? Shares of ITHUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryAgriculture Current SymbolOTCMKTS:ITHUF CIK1643154 Webwww.ianthuscapital.com Phone646-518-9411FaxN/AEmployees1,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.03 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (OTCMKTS:ITHUF) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iAnthus Capital Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iAnthus Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.